Skip to main content
Figure 4 | Molecular Medicine

Figure 4

From: TH2-like Chemokine Patterns Correlate with Disease Severity in Patients with Recurrent Respiratory Papillomatosis

Figure 4

Plasma CCL18 levels decrease in concert with improved clinical status in patients treated with celecoxib, a COX-2 inhibitor. Three patients (A,B,C) in the pilot clinical trial had CCL18 levels (solid line) measured by a single-plex ELISA in plasma samples collected at varying times during the study. Clinical improvement, denoted by reduction in severity score (gray bars), correlated with decreasing CCL18 concentrations.

Back to article page

Molecular Medicine

ISSN: 1528-3658